14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 52 days ( 0 % )
Last Price $15.31 0 %
High/ Low $15.31 - $15.31 0%
Chg 7 Days N/A $15.31 $15.31
Chg 30 Days N/A $15.31 $15.31
Chg 12 mos 136.27 % $6.48 $15.31
Trend - 3 mos -0.105 % Width: 0.91 %
Trend - 12 mos 91.41 % Width: 83.75 %
Pred. range - 3 mos $15.28 - $15.42 -0.195 % - 0.717 %
Pred. range - 12 mos $20.75 - $38.12 35.50 % - 148.99 %
Short MA avg 3 mos Sell Feb 15, 2024 - 55 days
Long MA avg 3 mos Sell Mar 12, 2024 - 38 days
Short/Long MA avg 3 mos Sell Mar 12, 2024 - 38 days
Short MA avg 12 mos Sell Feb 21, 2024 - 52 days
Long MA avg 12 mos Sell May 02, 2024 - 2 days
Short/Long MA avg 12 mos Sell May 02, 2024 - 2 days
Pivot Short Sell Feb 16, 2024 - 54 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Icosavax, Inc.

Icosavax. Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumo... ICVX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT